Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Fogelman

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 23, 2005
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null miceMohamad Navab, G M Anantharamaiah, Susan Hama, et al.
Molecular Genetics and Metabolism|July 13, 2010
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levelsSatoshi Imaizumi, Victor Grijalva, Saul Priceman, et al.
Molecular Cancer Therapeutics|March 15, 2012
HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancerFeng Su, Victor Grijalva, Kaveh Navab, et al.
Cell Stem Cell|February 4, 2018
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and TumorigenesisBo Wang, Xin Rong, Elisa N D Palladino, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 22, 2010
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient miceNosratola D Vaziri, Hyun Ju Kim, Hamid Moradi, et al.
The Journal of Biological Chemistry|August 8, 2006
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2Carey J Ng, Noam Bourquard, Victor Grijalva, et al.
Antioxidants (Basel, Switzerland)|January 16, 2019
PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced ObesityDiana M Shih, Yonghong Meng, Tamer Sallam, et al.
Journal of Lipid Research|March 8, 2008
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patientsLeanne T Bloedon, Richard Dunbar, Danielle Duffy, et al.
Circulation|November 26, 2003
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatmentBenjamin J Ansell, Mohamad Navab, Susan Hama, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2008
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritisChristina Charles-Schoeman, Mona Lisa Banquerigo, Susan Hama, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Arteriosclerosis, Thrombosis, and Vascular Biology|April 23, 2005
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null miceMohamad Navab, G M Anantharamaiah, Susan Hama, et al.
Molecular Genetics and Metabolism|July 13, 2010
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levelsSatoshi Imaizumi, Victor Grijalva, Saul Priceman, et al.
Molecular Cancer Therapeutics|March 15, 2012
HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancerFeng Su, Victor Grijalva, Kaveh Navab, et al.
Cell Stem Cell|February 4, 2018
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and TumorigenesisBo Wang, Xin Rong, Elisa N D Palladino, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 22, 2010
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient miceNosratola D Vaziri, Hyun Ju Kim, Hamid Moradi, et al.
The Journal of Biological Chemistry|August 8, 2006
Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2Carey J Ng, Noam Bourquard, Victor Grijalva, et al.
Antioxidants (Basel, Switzerland)|January 16, 2019
PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced ObesityDiana M Shih, Yonghong Meng, Tamer Sallam, et al.
Journal of Lipid Research|March 8, 2008
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patientsLeanne T Bloedon, Richard Dunbar, Danielle Duffy, et al.
Circulation|November 26, 2003
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatmentBenjamin J Ansell, Mohamad Navab, Susan Hama, et al.
Clinical Immunology (Orlando, Fla.)|March 14, 2008
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritisChristina Charles-Schoeman, Mona Lisa Banquerigo, Susan Hama, et al.
Pageof 15